Neoadjuvant chemotherapy on advanced gastric carcinoma

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter A. Zemmour
Citation Annals of Oncology (2016) 27 (2): 86-101. 10.1093/annonc/mdw201
Authors A. Zemmour1, B. Larbaoui2, D. Yekrou3, Z. Boudinar Fatima2, K. Rekai4
  • 1Oncology Department Emir Abdelkader Oran, Oran, Algeria, /
  • 2Oncology Department, Oran, Algeria, /
  • 3Oncology Department, Sidi Belabes, Algeria, /
  • 4Medical oncology, EHSO Emir Abdelkader, Oran, Algeria, /


The gastric cancer is the second leading cause of cancer death worldwide. Surgery remains the most important and curative treatment of gastric cancer. Most of them are locally advanced at diagnosis and neoadjuvant chemotherapy should improve the resectability. We report our experience in management of unresectable locally gastric cancer.